Dr Aronstam sought a clinical trial exemption certificate to permit him to administer Mono-V3:C, a product of Speywood Laboratories, to 50 pupils over a period of 8 months.
Chronology Information
Date:
Chapter/issue
Treloars
Key Person(s)
Dr Anthony Aronstam